Withdrawn
Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis
Condition
Musculoskeletal
Skin
6 February 2026
Published on 03 May 2017
Last Updated on 06 February 2026
Guidance Recommendation
Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis Guidance is outdated and has been withdrawn on 6 February 2026.